Survival benefit with salvage radiotherapy for patients with locoregionally recurrent extranodal NK/T cell lymphoma, nasal type.

about

Consolidative treatment after salvage chemotherapy improves prognosis in patients with relapsed extranodal natural killer/T-cell lymphoma Salvage radiotherapy improves survival in patients with locoregionally relapsed stage IE-IIE extranodal natural killer/T-cell lymphoma, nasal type.

P2860

Q36760583-60F22163-41FE-46EB-922C-395F7B834DD3 Q55266534-2E5EC211-004D-42F7-BB8F-8C91E0062AEA

P2860

Survival benefit with salvage radiotherapy for patients with locoregionally recurrent extranodal NK/T cell lymphoma, nasal type.

Item

http://www.wikidata.org/entity/Q46424880

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Survival benefit with salvage ...... K/T cell lymphoma, nasal type.

@en

Survival benefit with salvage ...... K/T cell lymphoma, nasal type.

@nl

type

Item

label

Survival benefit with salvage ...... K/T cell lymphoma, nasal type.

@en

Survival benefit with salvage ...... K/T cell lymphoma, nasal type.

@nl

prefLabel

Survival benefit with salvage ...... K/T cell lymphoma, nasal type.

@en

Survival benefit with salvage ...... K/T cell lymphoma, nasal type.

@nl

P1476

Survival benefit with salvage ...... K/T cell lymphoma, nasal type.

@en

P2093

Bo Chen

http://www.w3.org/2001/XMLSchema#string

Hua Ren

http://www.w3.org/2001/XMLSchema#string

Hui Fang

http://www.w3.org/2001/XMLSchema#string

Jing Jin

http://www.w3.org/2001/XMLSchema#string

Ning-Ning Lu

http://www.w3.org/2001/XMLSchema#string

Qing-Feng Liu

http://www.w3.org/2001/XMLSchema#string

Shu-Lian Wang

http://www.w3.org/2001/XMLSchema#string

Shu-Nan Qi

http://www.w3.org/2001/XMLSchema#string

Ting Zhao

http://www.w3.org/2001/XMLSchema#string

Wei-Hu Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project.

Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience.

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.

Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.

Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan.

Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents.

Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma.

Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract.

Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma.

P304

325-332

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00277-012-1611-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23100164

http://www.w3.org/2001/XMLSchema#string

P921

extranodal NK/T-cell lymphoma, nasal type

Survival benefit with salvage radiotherapy for patients with locoregionally recurrent extranodal NK/T cell lymphoma, nasal type.

about

P2860

P2860

Survival benefit with salvage radiotherapy for patients with locoregionally recurrent extranodal NK/T cell lymphoma, nasal type.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921